Syneos Health
Syneos Health’s new president of clinical solutions, Paul Colvin, joins the company from PPD where he was the CRO’s executive vice president, biopharma partnerships. He also was chairman and CEO of the joint venture PPD-SNBL.
Before PPD, Colvin worked across a variety of roles at Eli Lilly and Company for nearly 15 years.
Colvin said, “I’m honored to join Syneos Health, an organization that I believe is well positioned to transform biopharmaceutical development and commercialization for both biotech and large pharma."
Colvin succeeds Michael McKelvey, PhD, who announced his retirement.